Arctis Global
Latest statistics and disclosures from Arctis Global's latest quarterly 13F-HR filing:
- Top 5 stock holdings are EWZ, XLE, EEM, REKR, XOP, and represent 81.75% of Arctis Global's stock portfolio.
- Added to shares of these 9 stocks: EEM (+$31M), XOP (+$15M), EWZ (+$14M), XLE (+$10M), URA (+$7.6M), FHN, REKR, ATRA, IOVA.
- Started 6 new stock positions in EEM, URA, IOVA, XOP, FHN, ATRA.
- Reduced shares in these 6 stocks: GDX (-$85M), TECK (-$50M), FTAI (-$17M), LMT (-$13M), GD (-$5.2M), COIN.
- Sold out of its positions in COIN, GD, GDX.
- Arctis Global was a net seller of stock by $-91M.
- Arctis Global has $185M in assets under management (AUM), dropping by -30.01%.
- Central Index Key (CIK): 0001831342
Tip: Access up to 7 years of quarterly data
Positions held by Arctis Global consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Arctis Global
Arctis Global holds 13 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Msci Brazil Etf (EWZ) | 24.4 | $45M | +42% | 1.5M | 30.67 |
|
| Select Sector Spdr Tr Energy (XLE) | 17.6 | $33M | +46% | 360k | 90.39 |
|
| Ishares Tr Msci Emg Mkt Etf (EEM) | 16.9 | $31M | NEW | 823k | 37.95 |
|
| Rekor Systems (REKR) | 14.7 | $27M | +4% | 9.6M | 2.82 |
|
| Spdr Ser Tr S&p Oilgas Exp (XOP) | 8.2 | $15M | NEW | 103k | 147.91 |
|
| Teck Resources CL B (TECK) | 4.2 | $7.8M | -86% | 181k | 43.09 |
|
| Global X Fds Global X Uranium (URA) | 4.1 | $7.6M | NEW | 280k | 27.04 |
|
| Pan American Silver Corp Can Call Option (PAAS) | 3.9 | $7.2M | 500k | 14.48 |
|
|
| Lockheed Martin Corporation (LMT) | 2.5 | $4.6M | -74% | 11k | 408.96 |
|
| First Horizon National Corporation (FHN) | 1.8 | $3.3M | NEW | 299k | 11.02 |
|
| Ftai Aviation SHS (FTAI) | 1.3 | $2.3M | -87% | 66k | 35.55 |
|
| Atara Biotherapeutics (ATRA) | 0.3 | $588k | NEW | 397k | 1.48 |
|
| Iovance Biotherapeutics (IOVA) | 0.2 | $397k | NEW | 87k | 4.55 |
|
Past Filings by Arctis Global
SEC 13F filings are viewable for Arctis Global going back to 2020
- Arctis Global 2023 Q3 filed Nov. 14, 2023
- Arctis Global 2023 Q2 filed Aug. 14, 2023
- Arctis Global 2023 Q1 filed May 15, 2023
- Arctis Global 2022 Q4 filed Feb. 14, 2023
- Arctis Global 2022 Q3 filed Nov. 14, 2022
- Arctis Global 2022 Q2 filed Aug. 15, 2022
- Arctis Global 2022 Q1 filed May 16, 2022
- Arctis Global 2021 Q4 filed Feb. 14, 2022
- Arctis Global 2021 Q3 filed Nov. 15, 2021
- Arctis Global 2021 Q2 filed Aug. 13, 2021
- Arctis Global 2021 Q1 filed May 14, 2021
- Arctis Global 2020 Q4 filed Feb. 12, 2021